Monopar Therapeutics Inc (MNPR) is trading down at $117.56 (-0.84%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.
Monopar Therapeutics director Kim Tsuchimoto sells $455,566 in shares
Monopar Therapeutics director Kim Tsuchimoto sells $455,566 in shares
Monopar Therapeutics director Raymond Anderson sells $351,835 in stock
Monopar Therapeutics director Raymond Anderson sells $351,835 in stock